A Multimodal Genotoxic Anticancer Drug Characterized by Pharmacogenetic Analysis in


Journal

Genetics
ISSN: 1943-2631
Titre abrégé: Genetics
Pays: United States
ID NLM: 0374636

Informations de publication

Date de publication:
07 2020
Historique:
received: 11 03 2020
accepted: 08 05 2020
pubmed: 18 5 2020
medline: 25 6 2021
entrez: 17 5 2020
Statut: ppublish

Résumé

New anticancer therapeutics require extensive

Identifiants

pubmed: 32414869
pii: genetics.120.303169
doi: 10.1534/genetics.120.303169
pmc: PMC7337070
doi:

Substances chimiques

Antineoplastic Agents 0
Benzothiazoles 0
CX 5461 0
Mutagens 0
Naphthyridines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

609-621

Subventions

Organisme : NIH HHS
ID : P40 OD010440
Pays : United States

Informations de copyright

Copyright © 2020 by the Genetics Society of America.

Références

Nat Commun. 2014;5:3216
pubmed: 24496117
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Genome Res. 2014 Oct;24(10):1624-36
pubmed: 25030888
Nucleic Acids Res. 2016 Jul 8;44(W1):W277-83
pubmed: 27185890
PLoS Genet. 2019 Feb 22;15(2):e1007992
pubmed: 30794539
Cell. 2013 Aug 29;154(5):1151-1161
pubmed: 23993102
Mol Cell. 2016 Aug 4;63(3):514-25
pubmed: 27453043
Nat Commun. 2017 Feb 17;8:14432
pubmed: 28211448
PLoS Genet. 2019 Feb 14;15(2):e1007975
pubmed: 30763314
Cell. 2016 Jul 28;166(3):740-754
pubmed: 27397505
DNA Repair (Amst). 2016 Oct;46:55-60
pubmed: 27497692
Cancer Res. 2011 Feb 15;71(4):1418-30
pubmed: 21159662
G3 (Bethesda). 2012 Nov;2(11):1415-25
pubmed: 23173093
DNA Repair (Amst). 2008 Nov 1;7(11):1846-54
pubmed: 18708164
Toxicology. 2011 Nov 18;289(2-3):91-102
pubmed: 21843585
Genetics. 1985 Mar;109(3):493-511
pubmed: 3979812
Acta Crystallogr D Biol Crystallogr. 2005 Jul;61(Pt 7):1009-12
pubmed: 15983425
EMBO J. 2007 Jul 25;26(14):3384-96
pubmed: 17611606
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
J Photochem Photobiol A Chem. 2009 Jan 1;201(1):50-56
pubmed: 20046228
DNA Repair (Amst). 2008 Feb 1;7(2):267-80
pubmed: 18053776
J Biol Chem. 2013 Feb 15;288(7):4567-82
pubmed: 23293027
Dermatol Clin. 2014 Jul;32(3):363-8, ix
pubmed: 24891058
Genetics. 2006 Jun;173(2):697-708
pubmed: 16547095
Sci Rep. 2018 Sep 6;8(1):13333
pubmed: 30190484
Nat Methods. 2013 Dec;10(12):1211-2
pubmed: 24097270
Sci Rep. 2017 Oct 3;7(1):12592
pubmed: 28974696
PLoS Genet. 2016 Oct 18;12(10):e1006368
pubmed: 27755535
Cancer Discov. 2019 Aug;9(8):1036-1049
pubmed: 31092402
Sci Transl Med. 2013 Aug 7;5(197):197ra102
pubmed: 23926200
Oncotarget. 2015 Jul 20;6(20):18094-104
pubmed: 26061708
BMC Pharmacol Toxicol. 2018 Apr 18;19(1):18
pubmed: 29669598
Nat Chem Biol. 2011 Feb;7(2):92-100
pubmed: 21186347
Genetics. 1974 May;77(1):71-94
pubmed: 4366476
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4053-4060
pubmed: 32041867
Toxicology. 2012 Dec 16;302(2-3):233-41
pubmed: 22917556
Genome Res. 2013 Oct;23(10):1749-62
pubmed: 23800452
Environ Health Perspect. 2013 Jun;121(6):717-24
pubmed: 23603051
Sci Transl Med. 2013 Aug 7;5(197):197ra101
pubmed: 23926199
Nature. 2012 Mar 28;483(7391):570-5
pubmed: 22460902
G3 (Bethesda). 2015 Dec 01;6(2):351-6
pubmed: 26628482
Photochem Photobiol Sci. 2018 Dec 5;17(12):1885-1903
pubmed: 30283959
Onco Targets Ther. 2016 Sep 29;9:5985-5997
pubmed: 27729807
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Photochem Photobiol. 2011 Nov-Dec;87(6):1214-29
pubmed: 21770950
Sci Rep. 2016 Mar 18;6:22965
pubmed: 26987796
Nat Genet. 2002 Aug;31(4):405-9
pubmed: 12101400
Mutat Res. 2000 Nov 20;455(1-2):29-60
pubmed: 11113466

Auteurs

Frank B Ye (FB)

Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada.

Akil Hamza (A)

Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada.

Tejomayee Singh (T)

Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada.

Stephane Flibotte (S)

Department of Zoology, University of British Columbia, Vancouver, V6T 1Z4, Canada.

Philip Hieter (P)

Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada hieter@msl.ubc.ca noneil@msl.ubc.ca.

Nigel J O'Neil (NJ)

Michael Smith Laboratories, University of British Columbia, Vancouver, V6T 1Z4, Canada hieter@msl.ubc.ca noneil@msl.ubc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH